Defining the apoptotic pathways underlying HDAC inhibitor-mediated tumor therapy in vivo

Lindemann, R., Newbold, A., Whitecross, K., Cluse, L., Frew, A., Ellis, L., Williams, S., Wiegmans, A., Dear, A., Scott, C., Pelligrini, M., Wei, A., Richon, V., Marks, P., Lowe, S. W., Smyth, M., Johnstone, R. (February 2008) Defining the apoptotic pathways underlying HDAC inhibitor-mediated tumor therapy in vivo. Onkologie, 31 (Suppl.). pp. 69-70. ISSN 0378-584X

URL: https://www.karger.com/Article/Abstract/115424

DOI: 10.1159/000115424

Item Type:	Paper
Additional Information:	Meeting Abstract
Subjects:	diseases & disorders > cancer diseases & disorders therapies organs, tissues, organelles, cell types and functions > cell types and functions > cell functions > apoptosis organs, tissues, organelles, cell types and functions > cell types and functions > cell functions organs, tissues, organelles, cell types and functions > cell types and functions Publication Type > Meeting Abstract organs, tissues, organelles, cell types and functions
CSHL Authors:	Lowe, Scott W.
Communities:	CSHL labs > Lowe lab
Depositing User:	Matt Covey
Date:	February 2008
Date Deposited:	28 Feb 2013 15:31
Last Modified:	19 Mar 2018 16:14
URI:	https://repository.cshl.edu/id/eprint/27510

Actions (login required)

Administrator's edit/view item